belatacept (active pharmaceutical ingredient from both Process E and Process C)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for belatacept (active pharmaceutical ingredient from both Process E and Process C), covering 2019-04-17 to 2019-04-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Compare the Pharmacokinetics of Belatacept Using Active Pharmaceutical Ingredient Manufactured by Process E Relative to Process C [Phase 1]